Table 2.
microRNA | HR (95% CI) | Heterogeneity test | Sample size | Expression | Outcome | Number of microRNA | |
---|---|---|---|---|---|---|---|
I2 (%) | Chi2 (P) | ||||||
miR-133b | 5.53 (2.58–11.83) | 0.0% | 0.939 | 100 | Low expression | OS/DFS | 2 |
miR-206 | 5.66 (2.69–11.88) | 0.0% | 0.914 | 100 | Low expression | OS/DFS | 2 |
miR-133b/206 | 9.48 (4.59–19.57) | 0.0% | 0.953 | 100 | Low expression | OS/DFS | 2 |
miR-195 | 4.23 (2.31–7.73) | 0.0% | 0.568 | 166 | Low expression | OS/DFS | 2 |
miR-152 | 0.13 (0.02–0.70) | – | – | 80 | Low expression | OS | 1 |
miR-223 | 4.59 (1.84–11.45) | – | – | 112 | Low expression | OS | 1 |
miR-326 | 3.90 (1.13–12.53) | – | – | 60 | Low expression | OS | 1 |
miR-95-3p | 4.22 (2.31–8.07) | – | – | 133 | Low expression | OS | 1 |
miR-497 | 3.96 (2.39–6.58) | 0.0% | 0.868 | 185 | Low expression | OS | 2 |
miR-491 | 3.06 (1.56–6.00) | 0.0% | 0.928 | 102 | Low expression | OS | 2 |
miR-124 | 3.73 (2.27–6.12) | 0.0% | 0.841 | 114 | Low expression | OS/DFS | 2 |
miR-491-5p | 2.68 (1.66–4.32) | 0.0% | 0.951 | 72 | Low expression | DFS/OS | 2 |
miR-101 | 4.16 (2.80–6.19) | 0.0% | 0.995 | 152 | Low expression | OS/RFS | 4 |
miR-139-5p | 3.03 (2.17–4.23) | 0.0% | 0.707 | 98 | Low expression | OS | 2 |
miR-29a | 5.68 (2.50–12.92) | 0.0% | 0.903 | 80 | High expression | OS/DFS | 2 |
miR-29b | 5.71 (2.58–12.67) | 0.0% | 0.904 | 80 | High expression | OS/DFS | 2 |
miR-196a | 6.59 (3.08–14.11) | 0.0% | 0.896 | 100 | High expression | OS/DFS | 2 |
miR-196b | 6.64 (3.09–14.24) | 0.0% | 0.900 | 100 | High expression | OS/DFS | 2 |
miR-196a/196b | 9.99 (4.82–20.69) | 0.0% | 0.979 | 100 | High expression | OS/DFS | 2 |
miR-221 | 7.26 (3.29–16.04) | 0.0% | 0.886 | 108 | High expression | RFS/OS | 2 |
miR-27a | 3.36 (1.90–5.95) | 0.0% | 0.851 | 166 | High expression | OS/DFS | 2 |
miR-191 | 3.05 (1.75–5.31) | 0.0% | 0.593 | 100 | High expression | OS/DFS | 2 |
miR-300 | 5.07 (3.41–7.54) | 0.0% | 0.958 | 114 | High expression | OS/DFS | 4 |
miR-542-3p | 7.83 (5.41–11.34) | 0.0% | 0.431 | 76 | High expression | OS/PFS | 4 |
miR-194 | 4.01 (2.53–6.36) | 0.0% | 0.695 | 124 | Low expression | OS/DFS | 2 |
DFS, Disease-free survival; OS, Overall survival; RFS, Recurrence-free survival; PFS, Progression-free survival; –, Not available.